Publikationen in Zusammenarbeit mit Forschern von University of Bern (26)

2024

  1. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

    Gut, Vol. 73, Núm. 7, pp. 1183-1198

2023

  1. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

2022

  1. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

2021

  1. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350

  2. Transcriptomic profiling of the liver sinusoidal endothelium during cirrhosis reveals stage-specific secretory signature

    Cancers, Vol. 13, Núm. 11

2020

  1. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

    Journal of Hepatology, Vol. 73, Núm. 6, pp. 1415-1424

  2. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 4, pp. 963-973.e14

  3. Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 313-327.e6

  4. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    Journal of Hepatology, Vol. 72, Núm. 5, pp. 885-895

  5. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

  6. The gut-liver axis in liver disease: Pathophysiological basis for therapy

    Journal of Hepatology, Vol. 72, Núm. 3, pp. 558-577

  7. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis

    Journal of Hepatology, Vol. 72, Núm. 6, pp. 1140-1150

2019

  1. Aging influences hepatic microvascular biology and liver fibrosis in advanced chronic liver disease

    Aging and Disease, Vol. 10, Núm. 4, pp. 684-698

  2. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis

    Journal of Hepatology, Vol. 71, Núm. 6, pp. 1126-1140

  3. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe

    Journal of Hepatology, Vol. 70, Núm. 3, pp. 398-411

  4. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    The Lancet, Vol. 394, Núm. 10215, pp. 2184-2196

  5. Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study

    Hepatology, Vol. 69, Núm. 1, pp. 282-293

  6. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

    The Lancet, Vol. 393, Núm. 10181, pp. 1597-1608

2018

  1. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis

    Gastroenterology, Vol. 154, Núm. 6, pp. 1694-1705.e4

  2. Effects of aging on liver microcirculatory function and sinusoidal phenotype

    Aging Cell, Vol. 17, Núm. 6